PARK CITY—July 15, 2015—Distal Access announced that it sold rights to its SPINR platform for peripheral vascular, coronary vascular, and endoscopic use to Merit Medical System’s NRI Limited, Dublin, Ireland.
The SPINR High-Performance Guidewire Controller is an award-winning system with issued and pending U.S. and international patents designed to improve guidewire control, torque, and performance. The SPINR Macerator is a simple and cost-effective way to macerate thrombus (blood clot).
Distal Access announced FDA clearance for the SPINR High-Performance Guidewire Controller to maneuver guidewires in the coronary and peripheral vasculature during interventional and diagnostic procedures in February this year. SPINR Macerators are under development and not FDA cleared at this time.
RM Global Partners LLC provided strategic advice to Distal Access in connection with this transaction www.rmglobal.com. Terms of the deal were not announced.
About Distal Access
Distal Access, LLC innovates, develops, and sells cost-effective medical devices to help clinicians improve patient care. The company's SPINR, RESECTR, and DRIVR platforms help clinicians control guidewires and macerate thrombus; perform uterine tissue resection, arthroscopic shaving, and general tissue removal; and perform cost-effective rotational vacuum-assisted biopsy, bone biopsy, intraosseous access, K-wire access, and tubes clearing with a simple 100% disposable non-powered system.